Genetic Analysis
1.16
NOK
-7.2 %
Less than 1K followers
GEAN
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
-7.2%
-18.31%
+36.47%
+127.45%
+118.87%
+75.76%
-67.51%
-
-89.16%
Genetic Analysis operates in medical technology. The company conducts research and development in the field of diagnostics, with the main focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.
Read moreMarket cap
74.56M NOK
Turnover
31.36K NOK
Revenue
15.89M
EBIT %
-89.49 %
P/E
-
Dividend yield-%
-
Financial calendar
27/8
2025
Interim report Q2'25
27/11
2025
Interim report Q3'25
25/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Genetic Analysis AS: Correction: Publication of Q1 report January - March 2025
Genetic Analysis AS: Genetic Analysis announces details of Subsequent Offering following directed issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools